Volcano Corporation (VOLC)

Volcano Corporation designs, develops, manufactures, and commercializes a suite of precision guided therapy tools worldwide. The company operates in two segments, Medical and Industrial. It offers intravascular ultrasound (IVUS) and fractional flow reserve (FFR) products that enhance the diagnosis and treatment of coronary and peripheral vascular disease by enhancing the efficiency and efficacy of existing diagnostic angiograms and percutaneous coronary interventional and endovascular procedures in the coronary arteries or peripheral arteries and veins. The company’s IVUS products include single-procedure disposable phased array and rotational IVUS imaging catheters; and ChromaFlo stent apposition analysis technology that uses sequential IVUS frames to differentiate circulating blood from stationary or anchored tissue. Its FFR products comprise pressure and flow consoles, and single-procedure disposable pressure and flow guide wires, which are used to measure the pressure and flow characteristics of blood around plaque enabling physicians to gauge the plaque’s physiological impact on blood flow and pressure. In addition, the company offers adenosine-free Instant Wave-Free Ratio FFR; and SyncVision, which co-registers IVUS with angiography. Further, the company develops and manufactures optical monitors for the telecommunication industry; laser and non-laser light sources; and sub-systems used in spectroscopy and other industrial applications. It sells its products through direct sales force and distributors, as well as through supply and distribution agreements with third parties. Volcano Corporation was founded in 2000 and is headquartered in San Diego, California. As of February 17, 2015, Volcano Corporation operates as a subsidiary of Philips Holding USA Inc.Philips Image Guided Therapy Corporation operates as a subsidiary of Koninklijke Philips N.V.